David Walsh

Cooley advised Takara Bio, a global biotechnology and life sciences company headquartered in Shiga, Japan, on its acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

Cooley advised Halcyon on its $100 million Series C funding. Partner Derek Colla led the Cooley team advising Halcyon, an organization devoted to defeating ransomware through prevention and resilience by way of a proprietary technology that captures encryption keys, enabling organizations to recover from attacks in minutes without paying ransom.

Cooley advised Expert Institute (EI), a provider of outsourced legal services to the attorney market, on its acquisition by Levine Leichtman Capital Partners, a Los Angeles-based private equity firm, from Spectrum Equity, a growth equity firm that provides capital and strategic support to innovative companies in the information economy, in partnership with management.

Cooley advised Second Front Systems (2F), a public-benefit software company focused on enabling the delivery of mission-critical software solutions, on the close of its $70 million Series C funding round.

Cooley advised Mott Corporation – a microfiltration business specializing in the design, customization, and manufacturing of sintered porous metal components and engineered solutions used in fluidic applications – on its definitive agreement to sell to IDEX Corporation for cash consideration of $1 billion, subject to customary adjustments.